Meta分析:放射状瘢痕与乳腺MRI
该系统综述与Meta分析检索MEDLINE和EMBASE数据库,评估乳腺对比增强MRI在钼靶检出放射状瘢痕中的获益,主要终点为MRI表现与最终结局(单纯放射状瘢痕 versus 放射状瘢痕伴不典型增生或恶性)的相关性;共纳入3项研究,每项研究的阴性预测值均为100%;作者认为高阴性预测值可能允许在MRI阴性时推迟活检、改为短期影像随访。
要点
- 钼靶检出放射状瘢痕时,乳腺对比增强MRI阴性者的阴性预测值在纳入的每项研究中均为100%。
- 作者认为MRI阴性时可能可推迟活检、改为短期影像随访。
- 该结论基于仅3项研究的系统综述与Meta分析。
核心结论
- 乳腺对比增强MRI在钼靶检出放射状瘢痕时具有高阴性预测值,每项纳入研究的阴性预测值均为100%。
- 作者认为该高阴性预测值可能允许在MRI阴性时推迟活检、改为短期影像随访。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE和EMBASE数据库,检索于2022年进行。
- 依据PRISMA指南进行分析。
- 共纳入3项研究。
- 主要终点为乳腺对比增强MRI表现与放射状瘢痕最终结局(单纯放射状瘢痕 versus 放射状瘢痕伴不典型增生或恶性)之间的相关性。
诊断标准与关键数值
- 每项纳入研究的阴性预测值均为100%,用于排除放射状瘢痕伴不典型增生或恶性。
临床应用与阅片要点
- 作者认为,在乳腺对比增强MRI阴性的放射状瘢痕病例中,高阴性预测值可能允许推迟活检、改为短期影像随访。
局限性
- 仅3项研究可用。
- 关于不典型增生与乳腺对比增强MRI的数据很少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: The implementation of digital breast tomosynthesis has increased the detection of radial scar (RS). Managing this finding may be experienced as a clinical dilemma in daily practice. Breast Contrast-Enhanced MRI (CE-BMR) is a known modality in case of problem-solving tool for mammographic abnormalities. However, the data about AD and CE-BMR are scant.
OBJECTIVE: The purpose was to estimate the benefit of CE-BMR in the setting of RS detected mammographically through a systematic review and meta-analysis of the literature.
METHODS: A search of MEDLINE and EMBASE databases were conducted in 2022. Based on the PRISMA guidelines, an analysis was performed. The primary endpoint was the correlation between CE-BMR findings and definite outcome for RS (pure RS versus RS associated with atypia or malignancy).
RESULTS: Three studies were available. The negative predictive value (NPV) was 100% for each.
CONCLUSION: The high NPV could allow for deferral of a biopsy in favor of a short-interval imaging follow-up in the setting of a negative CE-BMR.
引用
- Ferre R, Covington MF, Kuzmiak CM, et al. Meta-analysis: Radial Scar and Breast MRI. Acad Radiol. 2024. PMID: 38714429. doi:10.1016/j.acra.2024.04.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。